Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Veronica S. Gil"'
Autor:
Veronica S. Gil, Govind Bhagat, Louise Howell, Jiyuan Zhang, Chae H. Kim, Sven Stengel, Francisco Vega, Arthur Zelent, Kevin Petrie
Publikováno v:
Disease Models & Mechanisms, Vol 9, Iss 12, Pp 1483-1495 (2016)
Histone deacetylase 9 (HDAC9) is expressed in B cells, and its overexpression has been observed in B-lymphoproliferative disorders, including B-cell non-Hodgkin lymphoma (B-NHL). We examined HDAC9 protein expression and copy number alterations in pri
Externí odkaz:
https://doaj.org/article/a02931d6d6d448e393a7ca0d30cc23bb
Autor:
Johann S. de Bono, Neil Pegg, Karen E. Knudsen, Matthew J. Schiewer, David Taddei, Amanda Swain, Jian Ning, Antje J. Neeb, Suzanne Carreira, Nina Tunariu, Rita Pereira, Ana Ferreira, Mateus Crespo, Susana Miranda, Veronica S. Gil, Gareth W. Harbottle, Don Smyth, Richard Brown, Silvia Paoletta, Jonathan Shannon, Stuart Onions, Jenny Worthington, Stuart Thomson, Jordan Lane, Amy Prosser, Meera Raja, Barbara Young, William West, Denisa Bogdan, Jan Rekowski, Bora Gurel, Ruth Riisnaes, Ines Figueiredo, Abhijit Pal, Saswati N. Chand, Christopher McNair, Wei Yuan, Nigel Brooks, Adam Sharp, Jonathan Welti
Resistance to androgen receptor (AR) blockade in castration-resistant prostate cancer (CRPC) is associated with sustained AR signaling, including through alternative splicing of AR (AR-SV). Inhibitors of transcriptional coactivators that regulate AR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c73d8a93c6f4a3feb2612ceef314ced
https://doi.org/10.1158/2159-8290.c.6549379
https://doi.org/10.1158/2159-8290.c.6549379
Autor:
Johann S. de Bono, Neil Pegg, Karen E. Knudsen, Matthew J. Schiewer, David Taddei, Amanda Swain, Jian Ning, Antje J. Neeb, Suzanne Carreira, Nina Tunariu, Rita Pereira, Ana Ferreira, Mateus Crespo, Susana Miranda, Veronica S. Gil, Gareth W. Harbottle, Don Smyth, Richard Brown, Silvia Paoletta, Jonathan Shannon, Stuart Onions, Jenny Worthington, Stuart Thomson, Jordan Lane, Amy Prosser, Meera Raja, Barbara Young, William West, Denisa Bogdan, Jan Rekowski, Bora Gurel, Ruth Riisnaes, Ines Figueiredo, Abhijit Pal, Saswati N. Chand, Christopher McNair, Wei Yuan, Nigel Brooks, Adam Sharp, Jonathan Welti
Supplementary figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d313da933b889d09a6fcaf5a2385ff7
https://doi.org/10.1158/2159-8290.22540441.v1
https://doi.org/10.1158/2159-8290.22540441.v1
Autor:
Johann S. de Bono, Adam Sharp, Stephen R. Plymate, Christopher J. Schofield, Bissan Al-Lazikani, Andrea Alimonti, Nina Tunariu, Suzanne Carreira, Maryou B. Lambros, Susana Miranda, Mateus Crespo, Lorenzo Buroni, Veronica S. Gil, Rossitza Christova, Bora Gurel, Akane Kawamura, Martine Abboud, Marc A. Moesser, Md. Saiful Islam, Anthony Tumber, Patrizio Di Micco, Takuma Uo, Soojin Kim, Juan M. Jiménez-Vacas, Daniel Nava Rodrigues, Ruth Riisnaes, Ana Ferreira, Rita Pereira, Ines Figueiredo, Wei Yuan, Antje J. Neeb, Jonathan Welti, Alec Paschalis
Supplementary Figure from JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31bc8fda216d27d81ffbe7ee2ca708e6
https://doi.org/10.1158/0008-5472.22427590.v1
https://doi.org/10.1158/0008-5472.22427590.v1
Autor:
Johann S. de Bono, Adam Sharp, Stephen R. Plymate, Christopher J. Schofield, Bissan Al-Lazikani, Andrea Alimonti, Nina Tunariu, Suzanne Carreira, Maryou B. Lambros, Susana Miranda, Mateus Crespo, Lorenzo Buroni, Veronica S. Gil, Rossitza Christova, Bora Gurel, Akane Kawamura, Martine Abboud, Marc A. Moesser, Md. Saiful Islam, Anthony Tumber, Patrizio Di Micco, Takuma Uo, Soojin Kim, Juan M. Jiménez-Vacas, Daniel Nava Rodrigues, Ruth Riisnaes, Ana Ferreira, Rita Pereira, Ines Figueiredo, Wei Yuan, Antje J. Neeb, Jonathan Welti, Alec Paschalis
Supplementary Table from JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dbf18b25e3d8ff07736321b61556d50
https://doi.org/10.1158/0008-5472.22427587
https://doi.org/10.1158/0008-5472.22427587
Autor:
Johann S. de Bono, Adam Sharp, Stephen R. Plymate, Christopher J. Schofield, Bissan Al-Lazikani, Andrea Alimonti, Nina Tunariu, Suzanne Carreira, Maryou B. Lambros, Susana Miranda, Mateus Crespo, Lorenzo Buroni, Veronica S. Gil, Rossitza Christova, Bora Gurel, Akane Kawamura, Martine Abboud, Marc A. Moesser, Md. Saiful Islam, Anthony Tumber, Patrizio Di Micco, Takuma Uo, Soojin Kim, Juan M. Jiménez-Vacas, Daniel Nava Rodrigues, Ruth Riisnaes, Ana Ferreira, Rita Pereira, Ines Figueiredo, Wei Yuan, Antje J. Neeb, Jonathan Welti, Alec Paschalis
Endocrine resistance (EnR) in advanced prostate cancer is fatal. EnR can be mediated by androgen receptor (AR) splice variants, with AR splice variant 7 (AR-V7) arguably the most clinically important variant. In this study, we determined proteins key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8606cfe95f088ed08bde3c47fc7d4d73
https://doi.org/10.1158/0008-5472.c.6512749.v1
https://doi.org/10.1158/0008-5472.c.6512749.v1